B3GALT4 and Huntington disease: Although B3GALT4 mitigates ganglioside activity in neurodegenerative disorders, such as Huntington disease [29], it was also reported that gangliosides are related to the immunological pathophysiology of type 1 diabetes and to insulin resistance in type 2 diabetes [30], [31].